Literature DB >> 12780954

Successful local low-dose urokinase treatment of acquired thrombosis early after cardiothoracic surgery.

Jerome Pilloud1, Peter C Rimensberger, James Humbert, Michel Berner, Maurice Beghetti.   

Abstract

BACKGROUND AND
OBJECTIVE: Recent surgery (<or=10 days) is considered an absolute contraindication for thrombolytic therapy. We report the successful use of low doses of urokinase locally infused to dissolve an intravascular thrombosis in the early postoperative period after congenital heart surgery. PATIENTS: Two children, with catheter-related intravascular thrombosis after cardiac surgery, received urokinase treatment within 24 hrs and 6 days of surgery, respectively.
SETTING: Tertiary, 11-bed, pediatric intensive care unit.
INTERVENTIONS: Urokinase was administered through the catheter close to the site of thrombosis with a bolus of 4400 units/kg followed by a continuous infusion of 1300 units x kg(-1) x hr(-1). MAIN
RESULTS: Thrombosis resolved completely in both patients after 3 days of therapy. Signs of systemic thrombolysis were not observed.
CONCLUSIONS: A short course of local low-dose urokinase is feasible and seems to be effective for thrombolysis of catheter-related thrombosis early after cardiothoracic surgery. It was not associated with bleeding in the two cases presented. Further studies are required to confirm the safety of this approach and to define optimal dosing.

Entities:  

Year:  2002        PMID: 12780954     DOI: 10.1097/00130478-200210000-00005

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  1 in total

1.  Acute arterial thrombosis after covered stent exclusion of bleeding mycotic pseudoaneurysm: treatment using catheter-directed thrombolysis.

Authors:  Sarah Palestrant; M Grace Knuttinen; Ron C Gaba; James T Bui; Charles A Owens
Journal:  Int J Vasc Med       Date:  2011-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.